Beyond Documentary Compliance: Building Trusted Regulatory Foundations
In the globalization of pharmaceutical supply chains, GMP certificates and ISO certifications merely serve as entry tickets for business cooperation, rather than lifelong guarantees of product quality. For global pharmaceutical developers and Marketing Authorization Holders (MAHs), the genuine challenge lies in penetrating suppliers’ standardized documentation systems to identify their real-day production status and actual quality management performance. In China, suppliers may maintain impeccable paper trails, while substantial deviations exist between documented procedures and on-site operations. Such discrepancies constitute the root causes of quality incidents, product recalls and registration failures.
As your reliable local partner, our core value in GMP and compliance verification lies in uncovering operational truth behind formal documents. Amid increasingly rigorous global regulation, any hidden compliance flaw may evolve into fatal business risk. Rather than conducting superficial site visits, we benchmark against the world’s most stringent regulatory standards, conduct simulated official audits, in-depth data integrity verification and systematic gap analysis, and build a solid regulatory compliance firewall to ensure your entire supply chain is fully audit-ready for global regulatory inspections.
Simulated Official Audits: Pre-emptive Simulation of Regulatory Challenges
Our audit services adopt high-standard, high-rigorous simulated regulatory assessment rather than routine factory visits. Our expert team consists of seasoned ex-regulatory inspectors and senior QA professionals with in-depth knowledge of the inspection logic, key focus areas and enforcement benchmarks of leading global regulatory authorities, including FDA, EMA, NMPA and PIC/S member states.
• Benchmarking against the highest international standards: Our audits strictly comply with ICH Q7, EU GMP (EudraLex Volume 4) and FDA cGMP (21 CFR Part 210/211). We conduct item-by-item verification covering sterility assurance for sterile products, cross-contamination control for high-potency drugs and other critical scenarios in accordance with corresponding GMP annexes and guidelines. This ensures suppliers’ manufacturing systems comply not only with domestic Chinese GMP requirements but also seamlessly align with regulatory standards of target overseas markets.
• Systematic full-process audit framework: Our audits cover all dimensions of the Quality Management System (QMS), including personnel qualification and training, facility and equipment qualification (DQ/IQ/OQ/PQ), material management, laboratory QC control, production operation, as well as product distribution and recall management. We place particular emphasis on the implementation of Quality by Design (QbD) principles, and the scientificity and adequacy of process validation and cleaning validation, ensuring sustained validated status of commercial manufacturing processes.
• Identifying implicit operational risks and cultural discrepancies: With profound insight into local industrial practices, our professionals effectively identify implicit operational irregularities and habitual non-compliant behaviors commonly found among Chinese manufacturers but rarely observed in Western audits. We bridge cross-border quality culture gaps, interpret implicit regulatory expectations, and translate abstract regulatory intent into concrete, implementable rectification requirements for local suppliers.
Data Integrity Verification: Safeguarding the Lifeline of Pharmaceutical Quality
Over the past decade, data integrity has become the top priority of global regulatory inspections and the primary cause of FDA 483 observations, warning letters and import bans. The authenticity and reliability of data fundamentally determine pharmaceutical product safety, efficacy and quality controllability. Our professional verification services ensure all supplier-generated data fully comply with ALCOA+ principles, namely Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring and Available.
• In-depth review of computerized systems: In strict accordance with FDA 21 CFR Part 11 and EU GMP Annex 11, we conduct rigorous audits on computerized systems including LIMS, CDS, ERP and SCADA. We verify the implementation of duty segregation in user permission management, detect shared accounts and excessive super administrator privileges, confirm the mandatory activation and non-modifiable nature of audit trails for full recording of data creation, modification and deletion activities, and validate the compliance of electronic signature management.
• Detective investigation of laboratory data authenticity: Laboratories are high-risk scenarios for data irregularities. Our experts conduct thorough detective-style reviews of original chromatograms, instrument logs and operating records to identify prevalent non-compliant behaviors such as testing into compliance, selective data reporting, and deletion or concealment of out-of-specification results. We verify injection sequences, integration parameters and method version control to guarantee the authenticity and credibility of analytical data.
• Cross-verification of paper and electronic records: Beyond electronic data review, we standardize the management of paper-based documentation. By cross-checking batch production records, batch testing reports, equipment logs and personnel attendance records, we effectively detect delayed documentation, post-event retrospective entry and record forgery, ensuring full, truthful and traceable documentation of all GMP activities.
Gap Analysis and CAPA Guidance: Closed-Loop Management from Risk Identification to Root Resolution
Audits are designed to drive quality improvement rather than simply identify defects. Upon completion of on-site assessments, we deliver detailed gap analysis reports and provide professional guidance for suppliers to formulate effective Corrective and Preventive Actions (CAPA).
• Risk-based gap assessment: Our reports avoid simplistic defect listing. We conduct hierarchical risk classification of critical, major and minor non-conformities, evaluate their potential impact on patient safety, product quality and data reliability, specify precise gaps between current systems and target regulatory standards such as FDA cGMP, and elaborate underlying regulatory logic to achieve credible and executable rectification outcomes.
• Scientific and practical CAPA planning: We assist suppliers in developing standardized CAPA plans centered on scientific Root Cause Analysis (RCA). We require suppliers to move beyond superficial corrective measures such as rework and retraining, dig deep into systemic root causes of non-conformities, and formulate targeted preventive measures to eliminate recurring risks at the system level. All CAPA plans are strictly reviewed for rationality and feasibility with clear completion timelines.
• CAPA effectiveness tracking and confirmation: Closed-loop CAPA management defines audit success. We continuously track CAPA implementation progress, verify submitted supporting evidence, and conduct remote or on-site follow-up audits whenever necessary to confirm the full implementation and effectiveness of rectification measures. We only recommend qualified suppliers to clients after all major and critical non-conformities are fully resolved, ensuring all cooperative manufacturers possess sustainable compliant production capabilities.
Supported by this rigorous, regulation-centric GMP and compliance verification system, we minimize your supply chain quality risks. More than professional auditors, we serve as your dedicated quality outpost in China, ensuring every supplier you engage and every batch of product you manufacture can withstand the most stringent inspections from global regulatory authorities.
